Table 5.

Predictors of Utilization of Lower-Mortality Centers Multivariate Analyses

OR95% CIPValue
InsuranceManaged.53.45,.63<.001
Medicaid.71.61,.84<.001
Indemnity1.00
Race/ethnicityWhite1.00
Hispanic.49.42,.57<.001
Other.60.51,.72<.001
ProcedureAortic valve replacement.97.66,1.44NS
Arterial switch (infant).89.66,1.20NS
Atrial septal defect.87.72,1.06NS
Atrial switch.97.58,1.61NS
Cavopulmonary shunt.93.70,1.23NS
Endocardial cushion defect1.03.80,1.32NS
Fontan1.01.76,1.32NS
Mitral valve replacement1.30.80,2.12NS
Norwood for HLHS1.10.71,1.71NS
Open valvuloplasty1.07.82,1.39NS
RV-to-PA conduit.68.42,1.10NS
Tetralogy of Fallot.90.72,1.12NS
TAPVR1.26.91,1.76NS
Transplant3.412.09,5.58<.001
Truncus arteriosus.82.48,1.41NS
Ventricular septal defect1.00
GeographicDistance to
Nearest LM hospital (/.1 log mile).81.80,.83<.001
Nearest HM hospital (/.1 log mile)1.241.21,1.26<.001
  • Dhosp indicates distance to the hospital of admission; DHM, distance to the nearest higher-mortality hospital; DLM, distance to the nearest lower-mortality hospital; HLHS, Norwood procedure for hypoplastic left heart syndrome; HM, higher-mortality hospital; LM, lower-mortality hospital; NS, not significant; RV-to-PA, right ventricular-to-pulmonary artery; TAPVR, total anomalous pulmonary venous return.